St Jude flat in Q2 – but could have been worse
This article was originally published in Clinica
Executive Summary
St Jude Medical saw flat sales during its second fiscal quarter, at $1.4 billion. Although not a great result, this was not as disastrous as analysts had predicted – they had expected a 4% drop in revenue, which would have marked a fifth consecutive quarter of year-on-year declines (www.clinica.co.uk, 16 July). St Jude’s Q2 earnings of $107 million fell short of the $244 million posted this time last year; but adjusted Q2 2013 net earnings were better, at $275 million or $0.96 per share, versus $276 million or $0.88 in Q2 2012.